Olga L. Bohn

773 total citations
18 papers, 352 citations indexed

About

Olga L. Bohn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Olga L. Bohn has authored 18 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Olga L. Bohn's work include Cancer Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Olga L. Bohn is often cited by papers focused on Cancer Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Olga L. Bohn collaborates with scholars based in United States, Mexico and Spain. Olga L. Bohn's co-authors include Sergio Sánchez-Sosa, Marino E. Leon, Julie Teruya‐Feldstein, Luis E. De Las Casas, Guillermo J. Ruíz‐Argüelles, Jocelyn Maragulia, Craig H. Moskowitz, Maria E. Arcila, Carla Casulo and Audrey H. Choi and has published in prestigious journals such as Clinical Cancer Research, World Journal of Gastroenterology and Journal of Gastrointestinal Surgery.

In The Last Decade

Olga L. Bohn

17 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga L. Bohn United States 11 141 90 81 77 65 18 352
P. Iyengar Canada 12 152 1.1× 105 1.2× 109 1.3× 150 1.9× 104 1.6× 24 517
Hiroyuki Yamaoka Japan 13 146 1.0× 81 0.9× 103 1.3× 69 0.9× 45 0.7× 37 471
Athina Androulaki Greece 12 148 1.0× 78 0.9× 45 0.6× 98 1.3× 145 2.2× 29 363
Elisabetta Froio Italy 14 189 1.3× 83 0.9× 88 1.1× 56 0.7× 53 0.8× 38 453
Johanna Rische Germany 8 71 0.5× 76 0.8× 231 2.9× 118 1.5× 39 0.6× 8 411
Michaela Bártů Czechia 11 112 0.8× 78 0.9× 82 1.0× 132 1.7× 36 0.6× 52 385
Jake Allred United States 8 258 1.8× 27 0.3× 57 0.7× 55 0.7× 83 1.3× 13 373
Alexandre Rouquette France 9 204 1.4× 81 0.9× 111 1.4× 87 1.1× 115 1.8× 28 416
Tien Anh N. Tran United States 12 125 0.9× 53 0.6× 142 1.8× 124 1.6× 50 0.8× 32 392
François‐Régis Ferrand France 11 211 1.5× 143 1.6× 96 1.2× 74 1.0× 34 0.5× 35 414

Countries citing papers authored by Olga L. Bohn

Since Specialization
Citations

This map shows the geographic impact of Olga L. Bohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga L. Bohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga L. Bohn more than expected).

Fields of papers citing papers by Olga L. Bohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga L. Bohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga L. Bohn. The network helps show where Olga L. Bohn may publish in the future.

Co-authorship network of co-authors of Olga L. Bohn

This figure shows the co-authorship network connecting the top 25 collaborators of Olga L. Bohn. A scholar is included among the top collaborators of Olga L. Bohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga L. Bohn. Olga L. Bohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Matsuki, Eri, Olga L. Bohn, Siraj M. El Jamal, et al.. (2018). Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With Rituximab. Applied immunohistochemistry & molecular morphology. 27(8). 572–580. 16 indexed citations
2.
Bohn, Olga L., Katharine C. Hsu, David M. Hyman, et al.. (2013). BRAF V600E Mutation and Clonal Evolution in a Patient With Relapsed Refractory Myeloma With Plasmablastic Differentiation. Clinical Lymphoma Myeloma & Leukemia. 14(2). e65–e68. 19 indexed citations
3.
Bohn, Olga L., Takahiro Maeda, Alexander Filatov, et al.. (2013). Utility of LRF/Pokemon and NOTCH1 Protein Expression in the Distinction Between Nodular Lymphocyte-Predominant Hodgkin Lymphoma and Classical Hodgkin Lymphoma. International Journal of Surgical Pathology. 22(1). 6–11. 6 indexed citations
4.
Bohn, Olga L., Jarett L. Feldman, Mark Heaney, & Julie Teruya‐Feldstein. (2013). Acute Myeloid Leukemia With t(9;11) (p22;q23) and Synchronous Langerhans Cell Histiocytosis. International Journal of Surgical Pathology. 22(2). 172–176. 5 indexed citations
5.
Casulo, Carla, Maria E. Arcila, Olga L. Bohn, et al.. (2013). Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma. Leukemia Research. 37(9). 1178–1183. 27 indexed citations
6.
Bohn, Olga L., et al.. (2012). Pulmonary artery sarcoma with angiosarcoma phenotype mimicking pleomorphic malignant fibrous histiocytoma: a case report. Diagnostic Pathology. 7(1). 154–154. 8 indexed citations
7.
Bohn, Olga L., Barbara Spitzer, Rachel Kobos, et al.. (2012). Posttransplant Lymphoproliferative Disorder Complicating Hematopoietic Stem Cell Transplantation in a Patient With Dyskeratosis Congenita. International Journal of Surgical Pathology. 21(5). 520–525. 8 indexed citations
8.
Choi, Audrey H., et al.. (2011). Inflammatory Myofibroblastic Tumor of the Small Bowel Mesentery: An Unusual Cause of Abdominal Pain and Uveitis. Journal of Gastrointestinal Surgery. 15(4). 584–588. 20 indexed citations
9.
Bohn, Olga L., Chengquan Zhao, & Mirka W. Jones. (2011). Unusual Ovarian Stromal Tumor with Radiation Changes Mimicking Carcinoma. Journal of Cancer. 2. 228–231.
10.
Bohn, Olga L., et al.. (2011). Urinary Bladder Paraganglioma in Childhood: A Case Report and Review of the Literature. Pediatric and Developmental Pathology. 14(4). 327–332. 7 indexed citations
11.
Bohn, Olga L., et al.. (2010). p16INK4a expression in basal-like breast carcinoma.. PubMed. 3(6). 600–7. 25 indexed citations
12.
Bohn, Olga L., et al.. (2010). Trabecular and Psammomatoid Juvenile Ossifying Fibroma of the Skull Base Mimicking Psammomatoid Meningioma. Head and Neck Pathology. 5(1). 71–75. 26 indexed citations
13.
Bohn, Olga L., et al.. (2009). Basal cell carcinoma of the prostate gland: a case report and brief review of the basal cell proliferations of the prostate gland. Annals of Diagnostic Pathology. 14(5). 365–368. 9 indexed citations
14.
Bohn, Olga L., Luis E. De Las Casas, & Marino E. Leon. (2009). Tumor-to-Tumor Metastasis: Renal Cell Carcinoma Metastatic to Papillary Carcinoma of Thyroid—Report of a Case and Review of the Literature. Head and Neck Pathology. 3(4). 327–330. 38 indexed citations
15.
Bohn, Olga L., Irem Nasir, Adam Brufsky, et al.. (2009). Biomarker profile in breast carcinomas presenting with bone metastasis.. PubMed. 3(2). 139–46. 27 indexed citations
16.
Ross, Douglas T., Gong Tang, Olga L. Bohn, et al.. (2008). Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials. Clinical Cancer Research. 14(20). 6602–6609. 44 indexed citations
17.
Bohn, Olga L., et al.. (2008). Identification of human papillomavirus in esophageal squamous papillomas. World Journal of Gastroenterology. 14(46). 7107–7107. 23 indexed citations
18.
Bohn, Olga L., et al.. (2007). Cutaneous Langerhans Cell Sarcoma: A Case Report and Review of the Literature. International Journal of Hematology. 85(2). 116–120. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026